29 09, 2021 Giuseppe Sberna et al., Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19 adlitterio663392022-10-21T08:57:11+02:00 Read More
23 09, 2021 Paola Ulivi et al., Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience adlitterio663392022-10-14T12:06:12+02:00 Read More
21 09, 2021 Carla Debernardi et al., Correction to: Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction adlitterio663392022-10-21T09:22:20+02:00 Read More
1 09, 2021 Carlotta Antoniotti et al., Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study adlitterio663392022-10-14T12:18:31+02:00 Read More
24 08, 2021 Umberto Malapelle et al., Reference standards for gene fusion molecular assays on cytological samples: an international validation study. adlitterio663392022-10-14T12:09:36+02:00 Read More
23 08, 2021 Martina Lorenzi et al., First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study. adlitterio663392021-08-23T12:10:15+02:00 Read More
19 08, 2021 Sabrina Rossi et al., Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC adlitterio663392022-10-21T09:20:25+02:00 Read More
5 08, 2021 Antonio Marchetti et al., Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network adlitterio663392022-10-13T16:30:06+02:00 Read More
22 07, 2021 Alessandro Pancrazzi et al., Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response adlitterio663392022-10-14T12:20:42+02:00 Read More
22 07, 2021 Pamela Trillo Aliaga et al., Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis. adlitterio663392022-10-21T09:25:42+02:00 Read More